Schedule 13D ownership disclosure
PHASEBIO PHARMACEUTICALS INC
Security class unavailable · CUSIP: 717224109
Event date: 2019-07-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,990,155
- Percent of class
- 7.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-205450
- Form type
- SC 13D
- Filer
- Hatteras Venture Advisors III, LLC
- CIK
- CIK 1674177
- Filed
- Jul 29, 2019
- Reporting period
- Jul 01, 2019
- Description
- Schedule 13D beneficial ownership